NCT02853162 Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study) Status TERMINATED Phase PHASE2
NCT02850809 Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors Status COMPLETED Phase N/A
NCT02849119 Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy Status UNKNOWN Phase NA
NCT02835833 Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02829775 A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies Status COMPLETED Phase PHASE2/PHASE3
NCT02811861 Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02809404 Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study) Status COMPLETED Phase N/A
NCT02795819 Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer Status TERMINATED Phase PHASE1
NCT02763761 An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo Status WITHDRAWN Phase PHASE2
NCT02762006 Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT02747173 Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques Status TERMINATED Phase N/A
NCT02718066 Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02687139 Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma Status COMPLETED Phase NA
NCT02671552 Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery Status WITHDRAWN Phase EARLY_PHASE1
NCT02645409 Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma Status COMPLETED Phase NA
NCT02626754 A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population Status TERMINATED Phase PHASE2
NCT02619253 Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma Status COMPLETED Phase PHASE1